Vithal Dahduk

Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada

Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.

Magellan Biotech, Inc. provides private equity services to biotechnology companies.

Winston & Strawn LLP provides legal services. Its service areas include antitrust & trade regulations, employment & labor relations, intellectual property, taxation & trusts, and estates to automotive, aviation, electric power, financial services, and health care. The company was founded by Frederick H. Winston in 1853 and is headquartered in Chicago, IL.

CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba.

1-800-DOCTORS, Inc. engages in providing health care services. It is a comprehensive resource for people seeking reliable information for making their most important healthcare decisions. The company is headquartered in Iselin, NJ.

Part of The Hong Kong University of Science & Technology, Biotechnology Research Corp. engages in biotechnology research and development. The company is based in Hong Kong, Hong Kong.

Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ.

Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada.

Geritrex Corp. specializes in the development and manufacturing of various skincare, personal care and over-the-counter (OTC) pharmaceutical products. The firm's products include antimicrobial, dandruff/seborrhic dermatitis, external analgesics/anti-itch, hemorrhoidal care, laxatives, oral mucosal agents, post natal care, skin protectants and skincare/moisturizing agents. The company was founded by Anthony Madaio in 1978 and is headquartered in Mount Vernon, NY.

KAM Scientific, Inc. manufactures and distributes microbial disinfectant spray solutions for laboratories, hospitals, dental offices, clinics and various medical and public health related facilities. It offers Virocidin-X, a disinfectant and deodorizer for cleaning bacteria, fungus, and viruses. The company was founded by Albert D. Friesen and is headquartered in Winnipeg, Canada.

Apicore LLC manufactures and distributes pharmaceutical products. The firm offers Alcaftadine, Ambrisentan, Anidulafungin, Bexarotene, Clofarabine, Fondaparinux Sodium, and Isosulfan Blue. The company was founded in 2004 and is headquartered in Somerset, NJ.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Sensible Medical Innovations Ltd. develops non-invasive devices for monitoring congestive heart failures. The firm also developed an imaging method for internal organs based on information technology. The company was founded by Nadav Mizrahi, Amir Soroka, Dan Rappaport, Amir Ronen and Shlomi Bergida in 2007 and is headquartered in Netanya, Israel.

Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada.

RK Pharma, Inc. develops, manufactures, and commercializes generic pharmaceutical products. The company is based in Pearl River, NY and has subsidiaries in the United States. The company was founded by Ravishanker Kovi. The CEO is George R. Thomas.

DiRx, Inc. is an online pharmacy that provides affordable FDA-approved generic medicines without the need for insurance. The company is based in East Brunswick, NJ and was founded by Satish Srinivasan, who has been the CEO since incorporation. DiRx offers a simplified model for businesses and community organizations to provide maintenance medicine to their members. The company was founded by industry experts who have streamlined the path between the manufacturer and the consumer, making more medicine accessible to more people.